door Buchro Duera-oh 4 jaren geleden
190
Meer zoals dit
Developing vaccine in the future
Recombinant vector vaccines
using a virus or bacterium from one disease essentially acts as a delivery device for an immunogenic protein from another infectious agent
DNA vaccines
DNA coding for a particular antigen
Subunit Vaccines
Recombinant vaccines
Produced through recombinant DNA technology
human papillomaviruses (HPVs)
Hepatitis B virus (HBV)
Conjugated vaccines
taken from the outside layer of encapsulated bacteria and join the molecules to carrier proteins
Polysaccharide vaccines
taken from the outside layer of encapsulated bacteria
Toxoid vaccines
Use a toxin (harmful product) made by the germ that causes a disease.
tetanus
Diptheria
Whole-Pathogen Vaccines
Inactivated vaccines
Produced by killing the pathogen with chemicals, heat or radiation
Live-attenuated vaccines
a version of the living microbe that has been weakened in the laboratory
Passive immunization
Obtained passively,no participation
Active or passive immunization
Produced actively by the host immune system
Modifying the immune response
- Giardia spp. -> malabsorption - Diphyllobotrium latum->pernecious anemia
- Ascaris lumbricoides or tapeworms->intestinal obstruction - Filarial parasites->obstruct the flow of lymph through lymphatics
-Staphylococcus aureus->Inflammation, Pus -Gram –ve bacteria -Ig production as neutralizing Abs
- Neisseria gonorrhoeae - Mycobacterium tuberculosis
- Activation of T cell -> (mainly Th1) resulted in macrophage activation
- Activated macrophage demonstrated the increasing killing activity
- Secreted IL-2 by infected macrophage sense NK cell activation and secretion of IFN-g resulted in macrophage activation